Mark Harre is a Director Clinical Scientist at AstraZeneca, where they currently lead research initiatives. Previously, Mark served as a Programme Manager at Takeda Global Research & Development from 2007 to 2012 and held the position of Senior Clinical Study Manager at Eisai Pharmaceuticals UK from 2002 to 2007. Mark's extensive freelance experience from 2012 to 2023 included roles with notable companies such as AstraZeneca, Pfizer UK, and Roche. Mark's academic background includes a BSc in Biology from the University of Southampton, earned between 1989 and 1993.
This person is not in the org chart
This person is not in any teams
This person is not in any offices